Enhancing the efficacy of antidepressants with psychotherapy

  title={Enhancing the efficacy of antidepressants with psychotherapy},
  author={Timothy J. Petersen},
  journal={Journal of Psychopharmacology},
  pages={19 - 28}
  • T. Petersen
  • Published 1 May 2006
  • Psychology, Medicine
  • Journal of Psychopharmacology
Even after optimal treatment with and response to antidepressant medications during acute treatment of major depressive disorder, residual symptoms are common. Patients with residual symptoms are at increased risk of relapse and recurrence. Research suggests that psychotherapy may play an important role in enhancing the effects of antidepressant drug therapy and improving patients' long-term prognosis. Psychotherapy targets specific symptoms associated with relapse (e.g., guilt, hopelessness… 

Figures and Tables from this paper

Combined treatment of depression.

Incidence and predictors of relapse during continuation treatment of major depression with SSRI, interpersonal psychotherapy, or their combination

The results suggest that greater initial depression severity, greater difficulty in stabilizing symptoms, and presence of residual mood spectrum symptoms once remission is achieved are predictive of relapse.

Residual Symptoms of Depression: Adjuvant Therapies

Residual Symptoms of Depression (SRD, in Spanish) are those that persist despite a good response to antidepressant drug treatment. They have a high incidence in the psychiatric clinic and are

Antidepressants and Psychological Treatment: Hard Reasons for Synergy

Present evidence as to synergizing psychological therapy and pharmacotherapy in mood disorders, reflecting the related brain systems and circulating biological substances is evaluated, finding Identified neuropsychobiological pathways were found, as well as appreciable evidence that, in depression, the synergy of both treatments can be expected to produce better results.

The Long-Term Effects of Psychotherapy Added to Pharmacotherapy on Morning to Evening Diurnal Cortisol Patterns in Outpatients with Major Depression

The superior outcomes of group psychotherapy added to pharmacotherapy for MDD outpatients could relate to decreasing the anxiety state and to producing long-term impacts on positive stress endocrine outcomes seen as a steeper diurnal cortisol pattern.

Effect of group cognitive-behavioral therapy on the quality of life and social functioning of patients with mild depression

Combined treatment with both antidepressants and group CBT is better than treatment with antidepressants alone, and these benefits persist for up to one year after the CBT sessions have ended.

A Systematic Review of the Combined Use of Electroconvulsive Therapy and Psychotherapy for Depression

This systematic review synthesizes extant data regarding the combined use of psychotherapy with ECT for the treatment of patients with severe major depressive disorder and offers the hypothesis that augmenting ECT with depression-specific psychotherapy represents a promising strategy for future investigation.

The Effect of Psychotherapy Added to Pharmacotherapy on Cortisol Responses in Outpatients With Major Depressive Disorder

It is suggested that CT produced a protective effect on outpatients with major depression, preventing the increased night salivary cortisol levels and the flatter diurnal cortisol pattern that tended to occur in MT.



Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy in improving outcomes in depression.

Cognitive therapy may play a role in improving remission rates and decreasing relapse and recurrence rates and there is a consistent suggestion of superior prophylaxis for patients receiving some type of sequenced or crossover treatment in which the delivery of antidepressant medication and structured antidepressant psychotherapy is combined.

Residual symptoms in depression An emerging therapeutic target

Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings.

The results challenge the assumption that long-term drug treatment is the only tool to prevent relapse in patients with recurrent depression and suggest CBT offers a viable alternative for other patients.

Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?

Both medication and certain targeted psychotherapies appear to be effective in the treatment of depression.

Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations.

New evidence is found in support of the widespread clinical impression that combined therapy is superior to psychotherapy alone for treatment of more severe, recurrent depressions.

Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.

Most patients with chronic forms of MDD sustained their acute phase response and more than 50% of partial remitters achieved full remission while continuing treatment with nefazodone, CBASP, or COMB, which was associated with less symptom re-emergence during the continuation phase than either monotherapy.

Prevention of relapse in residual depression by cognitive therapy: a controlled trial.

In this difficult-to-treat group of patients with residual depression who showed only partial response despite antidepressant treatment, cognitive therapy produced worthwhile benefit.

Effects of cognitive therapy on psychological symptoms and social functioning in residual depression

In patients showing only partial response to antidepressants, the addition of cognitive therapy produced modest improvements in social and psychological functioning.

Cognitive therapy vs medications in the treatment of moderate to severe depression.

Cognitive therapy can be as effective as medications for the initial treatment of moderate to severe major depression, but this degree of effectiveness may depend on a high level of therapist experience or expertise.

Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.

Cognitive therapy has an enduring effect that extends beyond the end of treatment and seems to be as effective as keeping patients on medication.